Your browser doesn't support javascript.
Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See.
Pischel, Lauren; Goshua, George.
  • Pischel L; Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
  • Goshua G; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.
Clin Infect Dis ; 73(11): 2119-2120, 2021 12 06.
Article in English | MEDLINE | ID: covidwho-1560009
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid